Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 78, pseudogene (RNU1-78P), is a genomic locus annotated as a pseudogene related to the U1 small nuclear RNA (snRNA) family[1][2]. Unlike functional U1 snRNA genes, which are critical components of spliceosomal ribonucleoprotein complexes involved in pre-mRNA splicing, pseudogenes such as RNU1-78P are typically the result of retrotransposition or duplications and do not produce a functional RNA or protein product. While some U1 snRNA pseudogenes have been shown to be weakly transcribed or associated with ribonucleoprotein particles, RNU1-78P is not documented as having any established biological function, therapeutic relevance, disease association, or known drug interactions[1][2]. It is therefore not considered a valid therapeutic target, and its clinical or functional significance remains unproven. RNU1-78P is representative of a large class of U1 snRNA pseudogenes scattered throughout the genome[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 78, pseudogene (RNU1-78P).